Dr. Alessia Fornoni, MD, PhD

Dr. Fornoni practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Fornoni's NPI, 1891724118, was assigned on June 30, 2006. Dr. Fornoni graduated from University of Pavia Faculty of Medicine in 1995. Dr. Fornoni holds Florida license ME92745.

Dr. Fornoni's primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Fornoni's primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. Dr. Fornoni is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fornoni practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Fornoni's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Fornoni is board certified in nephrology by the American Board of Internal Medicine. Dr. Fornoni is licensed in Florida.

Dmand AI lists acute kidney failure, chronic diabetes, chronic hypertension, chronic kidney disease, hypercalcemia, kidney cysts, kidney stone disease and parathyroid gland disorder among the conditions Dr. Fornoni treats.

CMS data shows 151 Medicare services from Dr. Fornoni across 2 procedure codes in 2024, all of them office visits, for 91 Medicare patients. Medicare paid $11,396 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Fornoni in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fornoni's median patient age at 72, with 44% women.

In 2024, Dr. Fornoni wrote 448 Medicare Part D claims for 93 patients. 82% of them were for generic drugs. CMS names the drug for 265 of them, across 12 drugs with 11 or more claims each, at $48,963 in total drug cost. In 2023, CMS named 317 claims across 14 drugs.

Dr. Fornoni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fornoni as offering telehealth.

Dmand AI links 171 papers to Dr. Fornoni, published from 2004 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Podocytes, Diabetic Nephropathies and Kidney. Dr. Fornoni has published most often in Kidney Int. Dr. Fornoni's most frequent co-authors are George W. Burke, MD, Oliver Lenz, MD and Camillo Ricordi, MD.

Dmand AI links Dr. Fornoni to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Macular dystrophy, corneal type 1, Nephrotic Syndrome and Proteinuria.

CMS Open Payments shows 100 general payments to Dr. Fornoni from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Travere Therapeutics, Inc. paid the most, $40,127. It also lists 1 research payment totaling $940 in 2020.

Dmand AI lists 5 awards for Dr. Fornoni, most recently Leadeship Award in 2019.

Dr. Fornoni graduated from University of Pavia Faculty of Medicine in 1995. Dr. Fornoni is a member of ASN.

Dr. Fornoni is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.